Home / Tags / Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim’s commercial manufacturing facility in Shanghai has been awarded as “Facility of the Year”

Boehringer Ingelheim Biopharmaceuticals China receives “Facility of the Year” Award

Tuesday, April 14, 2020

Boehringer Ingelheim Biopharmaceuticals China Ltd. has been awarded with a 2020 Facility of the Year Award (FOYA) from the International Society for Pharmaceutical Engineering (ISPE). The company received an Honorable Mention award for its commercial facility in Shanghai, which is located at Zhangjiang Hi-Tech Park, a...

Read more
Boehringer Ingelheim manufactures the first biopharmaceutical approved in China under new Marketing Authorization Holder contract manufacturing regulatory system

Boehringer Ingelheim manufactures first biopharmaceutical approved in China

Friday, January 10, 2020

Through its collaboration with Beigene, Ltd. and the provision of manufacturing services for their monoclonal antibody tislelizumab, Boehringer Ingelheim Biopharmaceuticals China is the first company to successfully apply the adopted Marketing Authorization Holder (MAH) system within the revised Chinese Drug...

Read more

Surftipps